CN1332707C - Formula of Chinese herbal medicine decoction distinguished from males and females and combined with Western medicine for curing hepatitis B - Google Patents
Formula of Chinese herbal medicine decoction distinguished from males and females and combined with Western medicine for curing hepatitis B Download PDFInfo
- Publication number
- CN1332707C CN1332707C CNB200410022991XA CN200410022991A CN1332707C CN 1332707 C CN1332707 C CN 1332707C CN B200410022991X A CNB200410022991X A CN B200410022991XA CN 200410022991 A CN200410022991 A CN 200410022991A CN 1332707 C CN1332707 C CN 1332707C
- Authority
- CN
- China
- Prior art keywords
- radix
- root
- fructus
- rhizoma
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a formula of Chinese herbal medicine decoction distinguished from males and females and combined with Western medicines for curing hepatitis B. The medicine for males is prepared from red sage root, pilose asiabell root, white atractylodes rhizome, poria, peach kernel, curcuma root, bupleurum root, officinal magnolia bark, melia toosendan, isatis root, giant knotwood, capillary wormwood herb, cyrtomium fortunei, flavescent sophora root, vietnamese sophora root, scutellaria root, cassia occidentalis, turtle shell, prepared fleece flower root, prepared solomonseal rhizome, glossy privet fruit, cherokee rose, mulberry, raw rhubarb, schisandra fruit, raw germinated barley, panax notoginseng, barbed skullcap herb, oldenlandia, herb of stringy stonecrop, Chinese date, licorice root, shrubby cordyline leaf and willow branchlet. The medicine for females is prepared from red sage root, Chinese angelica root, red peony root, white peony root, chuanxiong rhizome, bupleurum root, pilose asiabell root, white atractylodes rhizome, scutellaria root, officinal magnolia bark, corydalis, curcuma root, capillary wormwood herb, isatis root, giant knotwood, flavescent sophora root, vietnamese sophora root, cassia occidentalis, prepared fleece flower root, prepared solomonseal rhizome, glossy privet fruit, cherokee rose, mulberry, cyrtomium fortunei, schisandra fruit, raw germinated barley, panax notoginseng, barbed skullcap herb, oldenlandia, herb of stringy stonecrop, Chinese date, licorice root, shrubby cordyline leaf, willow branchlet and raw rhubarb.
Description
Technical field:
The present invention and field of medicaments are especially with the Chinese herbal medicine decoction of Western medicine combined treatment hepatitis B.
Technical background:
Type B viral hepatitis, because of it has stronger infectiousness, patient's extend over the entire globe, particularly torrid areas, sickness rate is higher, and is healthy very harmful to people.This disease does not still have special therapeutic method.General employing hepatic or antiviral drugs, immunity regulatin remedy (as recombinant human interferon alpha-2), curative effect is all not ideal enough.Patent of invention ZL99103284.5 technology discloses a kind of hepatitis B diseases, it is characterized in that being made up of Radix Sophorae Flavescentis, Rhizoma Polygoni Cuspidati, the Radix Astragali, Herba Taxilli, Herba Swertiae Mileensis, Cordyceps, Carapax et Plastrum Testudinis, Radix Notoginseng, and it is scientific to use Carapax et Plastrum Testudinis to lack in the medicine.Clinical findings, hepatitis B patient belongs to deficiency of yang of liver and kidney more, but not the hepatic and renal YIN deficiency, and Carapax et Plastrum Testudinis cures mainly the cloudy hyperactivity of fire that loses, so that this technology use Carapax et Plastrum Testudinis has is improper, has to lack the medicine that damp eliminating is reduced phlegm in this technology again, is difficult to guarantee therapeutic efficiency.
Summary of the invention:
The present invention discloses the Chinese herbal medicine decoction with Western medicine combined treatment hepatitis B in order to overcome the deficiency that technology is arranged.The objective of the invention is to realize by following scheme: it is according to men and women's feature difference, impose different medicine compositing formulas, male's medicine is made up of Radix Salviae Miltiorrhizae, Radix Codonopsis, the Rhizoma Atractylodis Macrocephalae, Poria, Semen Persicae, Radix Curcumae, Radix Bupleuri, Cortex Magnoliae Officinalis, Fructus Toosendan, Radix Isatidis, Rhizoma Polygoni Cuspidati, Herba Artemisiae Scopariae, Rhizoma Osmundae, Radix Sophorae Flavescentis, Radix Sophorae Tonkinensis, Radix Scutellariae, Semen Cassiae, Carapax Trionycis, Radix Polygoni Multiflori Preparata, Rhizoma Polygonati (processed), Fructus Ligustri Lucidi, Fructus Rosae Laevigatae, Fructus Mori, Radix Et Rhizoma Rhei, Fructus Schisandrae Chinensis, Fructus Hordei Germinatus, Radix Notoginseng, Herba Scutellariae Barbatae, Herba Hedyotidis Diffusae, Herba Sedi, Fructus Jujubae, Radix Glycyrrhizae, Folium cordylines fruticosae, Ramulus Salicis Babylonicae.Its ratio range is: Radix Salviae Miltiorrhizae 18~20g, Radix Codonopsis 10~12g, the Rhizoma Atractylodis Macrocephalae 15~18g, Poria 10~12g, Semen Persicae 8~12g, Radix Curcumae 10~12g, Radix Bupleuri 10~15g, Cortex Magnoliae Officinalis 15~18g, Fructus Toosendan 18~20g, Radix Isatidis 20~25g, Rhizoma Polygoni Cuspidati 25~30g, Herba Artemisiae Scopariae 20~25g, Rhizoma Osmundae 12~15g, Radix Sophorae Flavescentis 20~25g, Radix Sophorae Tonkinensis 20~25g, Radix Scutellariae 20~25g, Semen Cassiae 25~30g, Carapax Trionycis 15~18g, Radix Polygoni Multiflori Preparata 25~30g, Rhizoma Polygonati (processed) 25~30g, Fructus Ligustri Lucidi 20~25g, Fructus Rosae Laevigatae 20~25g, Fructus Mori 15~20g, Radix Et Rhizoma Rhei 10~15g, Fructus Schisandrae Chinensis 8~10g, Fructus Hordei Germinatus 20~25g, Radix Notoginseng 8~10g, Herba Scutellariae Barbatae 10~15g, Herba Hedyotidis Diffusae 10~15g, Herba Sedi 15~20g, Fructus Jujubae 15~20g, Radix Glycyrrhizae 4~8g, Folium cordylines fruticosae 10~12g, Ramulus Salicis Babylonicae 10~12g.Female pharmaceutical sterilization preparation is made up of Radix Salviae Miltiorrhizae, Radix Angelicae Sinensis, Radix Paeoniae Rubra, the Radix Paeoniae Alba, Rhizoma Chuanxiong, Radix Bupleuri, Radix Codonopsis, the Rhizoma Atractylodis Macrocephalae, Radix Scutellariae, Cortex Magnoliae Officinalis, Rhizoma Corydalis, Radix Curcumae, Herba Artemisiae Scopariae, Radix Isatidis, Rhizoma Polygoni Cuspidati, Radix Sophorae Flavescentis, Radix Sophorae Tonkinensis, Semen Cassiae, Radix Polygoni Multiflori Preparata, Rhizoma Polygonati (processed), Fructus Ligustri Lucidi, Fructus Rosae Laevigatae, Fructus Mori, Rhizoma Osmundae, Fructus Schisandrae Chinensis, Fructus Hordei Germinatus, Radix Notoginseng, Herba Scutellariae Barbatae, Herba Hedyotidis Diffusae, Herba Sedi, Fructus Jujubae, Radix Glycyrrhizae, Folium cordylines fruticosae, Ramulus Salicis Babylonicae, Radix Et Rhizoma Rhei.Its ratio range is: Radix Salviae Miltiorrhizae 18~20g, Radix Angelicae Sinensis 10~12g, Radix Paeoniae Rubra 10~12g, the Radix Paeoniae Alba 15~20g, Rhizoma Chuanxiong 10~12g, Radix Bupleuri 12~15g, Radix Codonopsis 10~15g, the Rhizoma Atractylodis Macrocephalae 15~18g, Radix Scutellariae 20~25g, Cortex Magnoliae Officinalis 15~18g, Rhizoma Corydalis 8~12g, Radix Curcumae 10~12g, Herba Artemisiae Scopariae 20~25g, Radix Isatidis 20~25g, Rhizoma Polygoni Cuspidati 25~30g, Radix Sophorae Flavescentis 20~25g, Radix Sophorae Tonkinensis 20~25g, Semen Cassiae 25~30g, Radix Polygoni Multiflori Preparata 25~30g, Rhizoma Polygonati (processed) 25~30g, Fructus Ligustri Lucidi 20~25g, Fructus Rosae Laevigatae 20~25g, Fructus Mori 15~20g, Rhizoma Osmundae 10~15g, Fructus Schisandrae Chinensis 8~10g, Fructus Hordei Germinatus 20~25g, Radix Notoginseng 8~10g, Herba Scutellariae Barbatae 10~15g, Herba Hedyotidis Diffusae 10~15g, Herba Sedi 15~20g, Fructus Jujubae 15~20g, Radix Glycyrrhizae 4~8g, Folium cordylines fruticosae 10~12g, Ramulus Salicis Babylonicae 10~12g, Radix Et Rhizoma Rhei 10~15g.
Medicine-feeding is a daily dose scope, is decocted in water for oral dose, and cooperates to take secret prescription handed down in the family from generation to generation celestial being side HONGLING DAN every day 2 times that separate case proposes patent application, and each 2~3g also cooperates and injects recombinant human interferon alpha-2.
The etiology and pathogenesis of viral property hepatitis B is: the resistance of the damp-phlegm stasis of blood causes functional activity of QI being not smooth, insoluble being difficult to resolve of liver blood virus, the heat stagnation expectorant stasis of blood, and stasis of blood poison pents up endosome, makes the liver catharsis not normal, the defeated cloth of impairing the spleen and stomach fortuneization and kidney, qiactivity of triple energizer imbalance.Invention treatment hepatitis B is the Therapeutic Principle with heat-clearing and toxic substances removing, invigorating the spleen to clear away damp pathogen, nourishing the liver and kidney, blood circulation promoting and blood stasis dispelling, strengthening vital QI to eliminate pathogenic factors in view of the above.The spleen has the function to transport and transform nutrients, the strong fortune of temper, and the essence of water and grain abundance could constantly be carried and nourish in liver, the liver effect of just can bringing into normal play.Blood stored in the liver, kidney storing essence, liver controlling conveyance and dispersion, the kidney master closes the Tibetan, " The liver and the kidney have a common source ", liver blood relies on the nourishing of kidney, so the present invention to control with spleen earlier with treating the liver be main points.Medication of the present invention has stronger specific aim, and compatibility science, celestial side's HONGLING DAN of in addition share has dispelling phlegm and eliminating dampness, the effect of yin nourishing pathogenic fire reducing, benefiting vital QI and blood, blood circulation promoting and blood stasis dispelling, blood circulation promoting, releasing blood disease, the recombinant human interferon alpha-2 of adapted has antiviral and immunoloregulation function simultaneously in addition, so the present invention can impel liver blood virus to continue to descend effectively, all eliminates until virus.
The specific embodiment:
Male's medicine optimum formula: Radix Salviae Miltiorrhizae 20g, Radix Codonopsis 12g, Rhizoma Atractylodis Macrocephalae 18g, Poria 12g, Semen Persicae 10g, Radix Curcumae 12g, Radix Bupleuri 15g, Cortex Magnoliae Officinalis 18g, Fructus Toosendan 20g, Radix Isatidis 25g, Rhizoma Polygoni Cuspidati 30g, Herba Artemisiae Scopariae 25g, Rhizoma Osmundae 15g, Radix Sophorae Flavescentis 25g, Radix Sophorae Tonkinensis 25g, Radix Scutellariae 25g, Semen Cassiae 30g, Carapax Trionycis 18g, Radix Polygoni Multiflori Preparata 30g, Rhizoma Polygonati (processed) 30g, Fructus Ligustri Lucidi 25g, Fructus Rosae Laevigatae 25g, Fructus Mori 20g, Radix Et Rhizoma Rhei 15g, Fructus Schisandrae Chinensis 10g, Fructus Hordei Germinatus 25g, Radix Notoginseng 10g, Herba Scutellariae Barbatae 15g, Hedyotidis Diffusae 15g, Herba Sedi 20g, Fructus Jujubae 20g, Radix Glycyrrhizae 8g, Folium cordylines fruticosae 12g, Ramulus Salicis Babylonicae 12g.
Female pharmaceutical sterilization preparation optimum formula: Radix Salviae Miltiorrhizae 20g, Radix Angelicae Sinensis 12g, Radix Paeoniae Alba 20g, Radix Paeoniae Rubra 12g, Rhizoma Chuanxiong 12g, Radix Bupleuri 15g, Radix Codonopsis 15g, Rhizoma Atractylodis Macrocephalae 18g, Radix Scutellariae 25g, Cortex Magnoliae Officinalis 18g, Rhizoma Corydalis 12g, Radix Curcumae 12g, Herba Artemisiae Scopariae 25g, Radix Isatidis 25g, Rhizoma Polygoni Cuspidati 30g, Radix Sophorae Flavescentis 25g, Radix Sophorae Tonkinensis 25g, Semen Cassiae 30g, Radix Polygoni Multiflori Preparata 30g, Rhizoma Polygonati (processed) 30g, Fructus Ligustri Lucidi 25g, Fructus Rosae Laevigatae 25g, Fructus Mori 20g, Rhizoma Osmundae 15g, Fructus Schisandrae Chinensis 10g, Fructus Hordei Germinatus 25g, Radix Notoginseng 10g, Herba Scutellariae Barbatae 15g, Herba Hedyotidis Diffusae 15g, Herba Sedi 20g, Fructus Jujubae 20g, Radix Glycyrrhizae 8g, Folium cordylines fruticosae 12g, Ramulus Salicis Babylonicae 12g, Radix Et Rhizoma Rhei 15g.
Sick row:
Bao Jiangjun, the woman, 17 years old, suffer from chronic viral hepatitis B three big sun, symptom: menoxenia, the right side of body is had a pain, lassitude, extremity are aching and limp unable, complexion is purple dark, be afraid of cold, To Be Protected from Heat, bitter taste halitosis, lower abdomen are had a pain, and treats 6 months through me, checks the DNA feminine gender comprehensively, live the Huaihua electricity affair division, phone: 0745~2252506.
Chen Kaiyue, man, 47 years old, principal in the Huaihua five, suffer from the chronic viral hepatitis B small three positive, and the height fatty liver, symptom: the right side of body is had a pain, and is uncomfortable in chest, abdominal distention big, spirit is because of tired, bitter taste xerostomia, soreness of waist pain, treated 4 months through me, the DNA feminine gender is checked in the treatment recovery from illness comprehensively, and fatty liver disappears.
Ni Manmei, the woman, 33 years old, suffer from the chronic viral hepatitis B small three positive, symptom: the right side of body is had a pain, breast adenalgia, menoxenia, lower abdominal pain, soreness of waist pain, lassitude, appetite is not good enough, the people becomes thin, and treats 4 months through me, checks the DNA feminine gender comprehensively, the fatty liver disappearance.Live development zone, sky, Huaihua lake.Phone: 0745~2353571.
Claims (2)
1, a kind of Chinese herbal medicine of and Western medicine combined treatment male hepatitis B, it is characterized in that, herbal raw material consists of Radix Salviae Miltiorrhizae 18~20g, Radix Codonopsis 10~12g, the Rhizoma Atractylodis Macrocephalae 15~18g, Poria 10~12g, Semen Persicae 8~12g, Radix Curcumae 10~12g, Radix Bupleuri 10~15g, Cortex Magnoliae Officinalis 15~18g, Fructus Toosendan 18~20g, Radix Isatidis 20~25g, Rhizoma Polygoni Cuspidati 25~30g, Herba Artemisiae Scopariae 20~25g, Rhizoma Osmundae 12~15g, Radix Sophorae Flavescentis 20~25g, Radix Sophorae Tonkinensis 20~25g, Radix Scutellariae 20~25g, Semen Cassiae 25~30g, Carapax Trionycis 15~18g, Radix Polygoni Multiflori Preparata 25~30g, Rhizoma Polygonati (processed) 25~30g, Fructus Ligustri Lucidi 20~25g, Fructus Rosae Laevigatae 20~25g, Fructus Mori 15~20g, Radix Et Rhizoma Rhei 10~15g, Fructus Schisandrae Chinensis 8~10g, Fructus Hordei Germinatus 20~25g, Radix Notoginseng 8~10g, Herba Scutellariae Barbatae 10~15g, Herba Hedyotidis Diffusae 10~15g, Herba Sedi 15~20g, Fructus Jujubae 15~20g, Radix Glycyrrhizae 4~8g, Folium cordylines fruticosae 10~12g, Ramulus Salicis Babylonicae 10~12g.
2, a kind of and Western medicine combined treatment women hepatitis B Chinese herbal medicine, it is characterized in that herbal raw material consists of: Radix Salviae Miltiorrhizae 18~20g, Radix Angelicae Sinensis 10~12g, Radix Paeoniae Rubra 10~12g, the Radix Paeoniae Alba 15~20g, Rhizoma Chuanxiong 10~12g, Radix Bupleuri 12~15g, Radix Codonopsis 10~15g, the Rhizoma Atractylodis Macrocephalae 15~18g, Radix Scutellariae 20~25g, Cortex Magnoliae Officinalis 15~18g, Rhizoma Corydalis 8~12g, Radix Curcumae 10~12g, Herba Artemisiae Scopariae 20~25g, Radix Isatidis 20~25g, Rhizoma Polygoni Cuspidati 25~30g, Radix Sophorae Flavescentis 20~25g, Radix Sophorae Tonkinensis 20~25g, Semen Cassiae 25~30g, Radix Polygoni Multiflori Preparata 25~30g, Rhizoma Polygonati (processed) 25~30g, Fructus Ligustri Lucidi 20~25g, Fructus Rosae Laevigatae 20~25g, Fructus Mori 15~20g, Rhizoma Osmundae 10~15g, Fructus Schisandrae Chinensis 8~10g, Fructus Hordei Germinatus 20~25g, Radix Notoginseng 8~10g, Herba Scutellariae Barbatae 10~15g, Herba Hedyotidis Diffusae 10~15g, Herba Sedi 15~20g, Fructus Jujubae 15~20g, Radix Glycyrrhizae 4~8g, Folium cordylines fruticosae 10~12g, Ramulus Salicis Babylonicae 10~12g, Radix Et Rhizoma Rhei 10~15g.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB200410022991XA CN1332707C (en) | 2004-03-18 | 2004-03-18 | Formula of Chinese herbal medicine decoction distinguished from males and females and combined with Western medicine for curing hepatitis B |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB200410022991XA CN1332707C (en) | 2004-03-18 | 2004-03-18 | Formula of Chinese herbal medicine decoction distinguished from males and females and combined with Western medicine for curing hepatitis B |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1562229A CN1562229A (en) | 2005-01-12 |
CN1332707C true CN1332707C (en) | 2007-08-22 |
Family
ID=34480191
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB200410022991XA Expired - Fee Related CN1332707C (en) | 2004-03-18 | 2004-03-18 | Formula of Chinese herbal medicine decoction distinguished from males and females and combined with Western medicine for curing hepatitis B |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1332707C (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1317024C (en) * | 2005-04-21 | 2007-05-23 | 王洪奎 | Chinese materia medica preparation for treating hepatitis b virus |
CN101590105B (en) * | 2008-05-30 | 2012-10-31 | 财团法人工业技术研究院 | Chinese medicinal herb extract for inducing immune cells to generate interferon and activated TOLL-like receptors and preparation method thereof |
CN101361946B (en) * | 2008-09-27 | 2011-03-30 | 杨玉刚 | Traditional Chinese medicine combination for treating hepatitis B |
CN105561188A (en) * | 2016-01-04 | 2016-05-11 | 四川双鑫生物科技有限公司 | Decoction for treating ascites due to cirrhosis and preparation method thereof |
CN106177796A (en) * | 2016-08-30 | 2016-12-07 | 刘仪龙 | For treating the Chinese medicine composition of hepatitis B |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1413606A (en) * | 2001-10-24 | 2003-04-30 | 邓大勇 | Medicine for treatment of hepatitis |
CN1421234A (en) * | 2002-12-13 | 2003-06-04 | 郭言勋 | Oral liquid for treating hepatitis B |
-
2004
- 2004-03-18 CN CNB200410022991XA patent/CN1332707C/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1413606A (en) * | 2001-10-24 | 2003-04-30 | 邓大勇 | Medicine for treatment of hepatitis |
CN1421234A (en) * | 2002-12-13 | 2003-06-04 | 郭言勋 | Oral liquid for treating hepatitis B |
Non-Patent Citations (3)
Title |
---|
乙型病毒性肝炎中医研究近况 汪保林,河南中医,第23卷第11期 2003 * |
试论肝炎的中医治疗 祖屋,湖南中医药导报,第1卷第5期 1995 * |
试论肝炎的中医治疗 祖屋,湖南中医药导报,第1卷第5期 1995;乙型病毒性肝炎中医研究近况 汪保林,河南中医,第23卷第11期 2003 * |
Also Published As
Publication number | Publication date |
---|---|
CN1562229A (en) | 2005-01-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102319407B (en) | Traditional Chinese medicine for treating gastroptosis and extraction method thereof | |
CN103784820A (en) | Traditional Chinese medicine formula for treating cariac blood stasis type coronary heart disease | |
CN102188560A (en) | Traditional Chinese medicine for treating hyperlipidemia | |
CN103860699B (en) | A kind of pharmaceutical composition for effecting a radical cure three-hypers | |
CN1772161A (en) | Chinese medicine prepn for treating semen abnormality | |
CN101987138A (en) | Chinese medicinal preparation for treating impotence | |
CN103656122B (en) | Chinese medicine for the treatment of fever caused by exogenous pathogenic factors and preparation method thereof | |
CN103212021A (en) | Traditional Chinese medicine composition used for treating chloasma | |
CN102205059A (en) | Chinese herbal medicine composition for treating liver cancer, stomach cancer, lung cancer and leukemia and preparation method thereof | |
CN1332707C (en) | Formula of Chinese herbal medicine decoction distinguished from males and females and combined with Western medicine for curing hepatitis B | |
CN1049827C (en) | Anti-cancer powder | |
CN1186687A (en) | Cancer preventing curing medicine series and its preparation | |
CN101491612B (en) | Medicine for treating mammary hyperplasia and early breast cancer | |
CN103446535B (en) | A kind of Miao Ethnomedicine for the treatment of coronary heart disease | |
CN102423441A (en) | Double-formula medicine for treating constipation and preparation method thereof | |
CN102641479B (en) | Drug composite for treating hepatitis c | |
CN101683446A (en) | Traditional Chinese medicine composition with function of invigorating circulation and reducing blood fat | |
CN105126022A (en) | Medicine for treating ichthyosis and preparation method of medicine | |
CN105853660A (en) | Method for synthesizing traditional Chinese medicine for treating diabetes | |
CN103212033B (en) | Drug composition for treating viral hepatitis | |
CN103768520A (en) | Lipomata nursing medicine and preparation method thereof | |
CN103169894A (en) | Traditional Chinese medicine composition for treating proteinuria | |
CN102309725B (en) | Traditional Chinese medicine preparation for treating hepatitis B cirrhosis and preparation method | |
CN102166303B (en) | Traditional Chinese medicine composition for treating chronic atrophic gastritis | |
CN102018930A (en) | Medicine composition for treating hepatitis B |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
DD01 | Delivery of document by public notice |
Addressee: Chen Shaoxian Document name: Notification to Pay the Fees |
|
DD01 | Delivery of document by public notice |
Addressee: Chen Shaoxian Document name: Notification of Termination of Patent Right |
|
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070822 Termination date: 20100318 |